Skip to main content

Peer Review reports

From: Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan

Original Submission
9 May 2018 Submitted Original manuscript
31 Jul 2018 Reviewed Reviewer Report - Akihito Tsubota
19 Jan 2019 Author responded Author comments - Yu-Kang Chang
Resubmission - Version 2
19 Jan 2019 Submitted Manuscript version 2
11 Feb 2019 Reviewed Reviewer Report - Akihito Tsubota
6 Mar 2019 Author responded Author comments - Yu-Kang Chang
Resubmission - Version 3
6 Mar 2019 Submitted Manuscript version 3
22 Mar 2019 Author responded Author comments - Yu-Kang Chang
Resubmission - Version 4
22 Mar 2019 Submitted Manuscript version 4
27 Mar 2019 Author responded Author comments - Yu-Kang Chang
Resubmission - Version 5
27 Mar 2019 Submitted Manuscript version 5
Publishing
31 Mar 2019 Editorially accepted
5 Apr 2019 Article published 10.1186/s12902-019-0362-7

You can find further information about peer review here.

Back to article page